Great West Life Assurance CO Apellis Pharmaceuticals, Inc. Transaction History

Great West Life Assurance CO

$58 Billion
Q4 2024

A detailed history of Great West Life Assurance CO transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 6,189 shares of APLS stock, worth $170,321. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,189

Previous 8,030 22.93%

Holding current value

$170,321

Previous $232,000 15.09%

% of portfolio

0.0%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	SELL	$26.18 - $35.42 $48,197 - $65,208	-1,841 Reduced 22.93%	6,189 $197,000
Q3 2024 Nov 13, 2024	SELL	$28.84 - $41.15 $308,761 - $440,551	-10,706 Reduced 57.14%	8,030 $232,000
Q2 2024 Aug 12, 2024	BUY	$38.07 - $59.71 $78,386 - $122,942	2,059 Added 12.35%	18,736 $719,000
Q1 2024 May 13, 2024	BUY	$55.39 - $72.47 $478,957 - $626,648	8,647 Added 107.68%	16,677 $981,000
Q4 2023 Feb 13, 2024	BUY	$37.14 - $64.82 $25,589 - $44,660	689 Added 9.39%	8,030 $478,000
Q3 2023 Nov 14, 2023	BUY	$23.65 - $89.22 $94,600 - $356,880	4,000 Added 119.72%	7,341 $279,000
Q2 2023 Aug 10, 2023	SELL	$76.68 - $93.31 $68,321 - $83,139	-891 Reduced 21.05%	3,341 $306,000
Q1 2023 May 12, 2023	SELL	$46.59 - $66.96 $13,324 - $19,150	-286 Reduced 6.33%	4,232 $280,000
Q4 2022 Feb 10, 2023	BUY	$43.24 - $61.04 $18,593 - $26,247	430 Added 10.52%	4,518 $235,000
Q3 2022 Nov 01, 2022	BUY	$44.76 - $69.66 $182,978 - $284,770	4,088 New	4,088 $278,000
Q1 2022 May 12, 2022	BUY	$35.46 - $54.12 $17,730 - $27,060	500 Added 15.46%	3,734 $202,000
Q2 2021 Aug 11, 2021	SELL	$40.9 - $64.9 $32,229 - $51,141	-788 Reduced 19.59%	3,234 $204,000
Q3 2020 Nov 17, 2020	BUY	$25.89 - $33.65 $97,812 - $127,129	3,778 Added 1548.36%	4,022 $121,000
Q3 2020 Nov 13, 2020	SELL	$25.89 - $33.65 $278,058 - $361,401	-10,740 Reduced 97.78%	244 $7,000
Q2 2020 Aug 17, 2020	BUY	$24.8 - $38.49 $204,401 - $317,234	8,242 Added 300.58%	10,984 $357,000
Q4 2019 Feb 11, 2020	BUY	$22.1 - $30.8 $60,598 - $84,453	2,742 New	2,742 $83,000
Q3 2019 Oct 25, 2019	SELL	$24.09 - $32.18 $144,660 - $193,240	-6,005 Closed	0 $0
Q3 2018 Nov 13, 2018	BUY	$16.57 - $21.03 $99,502 - $126,285	6,005 New	6,005 $107,000

Others Institutions Holding APLS

# of Institutions

302

Shares Held

123M

Call Options Held

2.63M

Put Options Held

845K

View Full List

About Apellis Pharmaceuticals, Inc.

Ticker APLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 109,865,000
Market Cap $3.02B
Description
Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...

More about APLS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Apellis Pharmaceuticals, Inc. Transaction History